Last reviewed · How we verify
NCT05826938
Can Virtual Reality Technology Improve the Patient Experience in Oocyte Retrieval?
NA trial testing Virtual reality technology in Infertility, Female in 82 participants. Status unknown.
1 March 2024
Quick facts
| Lead sponsor | Peter Humaidan |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 82 |
| Start date | 13 March 2023 |
| Primary completion | 1 March 2024 |
| Estimated completion | 13 March 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Virtual reality technology
Conditions studied
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Peter Humaidan — full company profile →
Who can join
Adults 18 to 40, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A non-pharmacological, non-blinded, randomized cohort study that will investigate the effect of Virtual Reality technology on the patient experience during oocyte retrieval. The primary objective of the trial is to investigate the impact of Virtual Reality technology on the patient experience
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05826938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual reality technology
Trials testing the same drug.
- NCT06562829 — The Main Content of This Study is to Use Virtual Reality Technology Combined With Local Anesthesia With Lidocaine Inject · NA · completed
Other recruiting trials for Infertility, Female
Currently open trials in the same condition.
- NCT06771401 — Identification of Biomarkers in Cervical Mucus · NA · recruiting
- NCT06984081 — CAPA In-vitro Oocyte Maturation · NA · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07175571 — SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques · NA · recruiting
- NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
Other Peter Humaidan trials
Trials by the same sponsor.
- NCT05846256 — Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment · unknown
- NCT05323513 — The Correlation Between Luteal Serum Progesterone and Live Birth Rate · unknown
- NCT04761250 — The Effect of a Multimodal Lifestyle Program on Male Fertility · NA · completed
- NCT04905771 — Characterizing Follicles From Auto-transplanted Ovarian Tissue · unknown
- NCT04393857 — The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05826938 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peter Humaidan
- Last refreshed: 28 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05826938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing